Xin‐Rong Yang

15.6k total citations · 4 hit papers
181 papers, 9.3k citations indexed

About

Xin‐Rong Yang is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Xin‐Rong Yang has authored 181 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Oncology, 72 papers in Cancer Research and 60 papers in Molecular Biology. Recurrent topics in Xin‐Rong Yang's work include Hepatocellular Carcinoma Treatment and Prognosis (43 papers), Cancer Genomics and Diagnostics (34 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers). Xin‐Rong Yang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (43 papers), Cancer Genomics and Diagnostics (34 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers). Xin‐Rong Yang collaborates with scholars based in China, Ethiopia and India. Xin‐Rong Yang's co-authors include Jia Fan, Jian Zhou, Shuang–Jian Qiu, Yun‐Fan Sun, Yang Xu, Bo Hu, Wei Guo, Ao Huang, Xin Zhang and Jian Zhou and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xin‐Rong Yang

176 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma

2014 1.6k citations Bo Hu, Xin‐Rong Yang et al. Clinical Cancer Research profile →
Targeted therapy for hepatocellular carcinoma

2020 508 citations Ao Huang, Xin‐Rong Yang et al. Signal Transduction and Targeted Therapy profile →
STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4

2017 436 citations Xin‐Rong Yang, Jia Fan et al. profile →
Fluorescent probes for the detection of disease-associated biomarkers

2022 199 citations Xin‐Rong Yang et al. Science Bulletin profile →

Peers

Countries citing papers authored by Xin‐Rong Yang

Since Specialization

Citations

This map shows the geographic impact of Xin‐Rong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin‐Rong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin‐Rong Yang more than expected).

Fields of papers citing papers by Xin‐Rong Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin‐Rong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin‐Rong Yang. The network helps show where Xin‐Rong Yang may publish in the future.

Co-authorship network of co-authors of Xin‐Rong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xin‐Rong Yang. A scholar is included among the top collaborators of Xin‐Rong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin‐Rong Yang. Xin‐Rong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spatial‒temporal heterogeneities of liver cancer and the discovery of the invasive zone 2025 ·Clinical and Translational Medicine ·Jiayan Yan, (unknown), Shiyu Zhang, Qichao Yu, Yijun Lu, Raymond Miao, Zhao–You Tang, (unknown), Liang Wu, Dan G. Duda, Jian Zhou, Xin‐Rong Yang	2
2	Exploring morphological heterogeneity of circulating tumor cells: machine learning-based approach for cell identification and prognostic implications 2025 ·Science Bulletin ·Pengxiang Wang, (unknown), Bin Duan, Jianwen Cheng, Yun‐Fan Sun, (unknown), Kaiqian Zhou, Yang Xu, (unknown), (unknown), Haimin Li, Xiaojuan Sun, Wei Guo, Jian Zhou, Qi Liu, Jia Fan, Xin‐Rong Yang	0
3	958P Utilizing personalized tumor-specific methylation haplotypes of circulating tumor DNA for monitoring minimal residual disease in hepatocellular carcinoma patients after curative resection 2024 ·Annals of Oncology ·Xin‐Rong Yang, Dandan Guo, (unknown), Mingjiang Xu, Y-H. Chen, Chengcheng Ma, Min‐Ying Su, Qiwei He, (unknown), Zhixi Su, Ran Liu, Jinhai Fan, Jian Zhou	2
4	Optimizing of a suitable protocol for isolating tissue‐derived extracellular vesicles and profiling small RNA patterns in hepatocellular carcinoma 2024 ·Liver International ·Wenjing Yang, (unknown), Jiyan Wang, (unknown), Tongtong Tian, (unknown), Lin Ding, Wei Chen, Hao Wang, Jie Zhu, Chunyan Zhang, Baishen Pan, (unknown), Jia Fan, Beili Wang, Xin‐Rong Yang, Wei Guo	2
5	PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions 2023 ·Cells ·(unknown), Linfeng Xu, Xingxing Jian, Jian Ouyang, Bo Hu, Xin‐Rong Yang, Tao Wang, Lu Xie	14
6	High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma 2022 ·Journal of Clinical Laboratory Analysis ·Anli Jin, Yihui Yang, Xi Su, Wenjing Yang, Te Liu, Wei Chen, Tong Li, Lin Ding, Hao Wang, Beili Wang, Baishen Pan, Jian Zhou, Jia Fan, Xin‐Rong Yang, Wei Guo	13
7	CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis 2022 ·Clinical and Translational Medicine ·Anli Jin, Chunyan Zhang, Wenjing Zheng, Jingrong Xian, Wenjing Yang, Te Liu, Wei Chen, Tong Li, Beili Wang, Baishen Pan, Qian Li, Jianwen Cheng, Pengxiang Wang, Bo Hu, Jian Zhou, Jia Fan, Xin‐Rong Yang, Wei Guo	26
8	Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence 2022 ·Signal Transduction and Targeted Therapy ·Shao‐Lai Zhou, Zheng‐Jun Zhou, Chengli Song, Haoyang Xin, Zhiqiang Hu, Chu‐Bin Luo, (unknown), Jia Li, Zhi Dai, Xin‐Rong Yang, Ying‐Hong Shi, Zheng Wang, Xiaowu Huang, Jia Fan, Jian Zhou	22
9	Determination of Triterpenoids and Phenolic Acids from Sanguisorba officinalis L. by HPLC-ELSD and Its Application 2021 ·Molecules ·Jiahui Sun, (unknown), (unknown), Zhenyue Wang, (unknown), Shuang Jiang, Xin‐Rong Yang, (unknown), (unknown), Chunjuan Yang	6
10	MicroRNA‐148b Inhibits the Malignant Biological Behavior of Melanoma by Reducing Sirtuin 7 Expression Levels 2020 ·BioMed Research International ·Rui Sun, (unknown), Xiaojing Fan, Qinqin Meng, (unknown), Xin‐Rong Yang, Kexiang Yan, Hui Deng	6
11	BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity 2020 ·Cell Death and Disease ·Wenjing Yang, Yun‐Fan Sun, Anli Jin, (unknown), Jie Zhu, Beili Wang, Yan Zhou, Chunyan Zhang, Hao Wang, Bo Hu, Pengxiang Wang, Te Liu, Baishen Pan, Jian Zhou, Jia Fan, Xin‐Rong Yang, Wei Guo	15
12	Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score‐matched survival analysis 2019 ·Cancer Medicine ·Yang Gao, Pengxiang Wang, Jianwen Cheng, Yun‐Fan Sun, Bo Hu, Wei Guo, Kaiqian Zhou, Yue Yin, Yuancheng Li, Jian Wang, Junfeng Huang, Shuang‐Jian Qiu, Jian Zhou, Jia Fan, Xin‐Rong Yang	15
13	MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53 2019 ·Cancer Letters ·Wei Wang, Jianwen Cheng, Jiang‐Jiang Qin, Bo Hu, Xin Li, Bhavitavya Nijampatnam, Sadanandan E. Velu, Jia Fan, Xin‐Rong Yang, Ruiwen Zhang	38
14	Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study 2018 ·Clinical Cancer Research ·Zheng Wang, Zhenggang Ren, Yi Chen, Jie Hu, Guo‐Huan Yang, Lei Yu, Xin‐Rong Yang, Ao Huang, Xin Zhang, Shao‐Lai Zhou, Hui‐Chuan Sun, Yanhong Wang, Ningling Ge, Xiaoyu Xu, Zhao–You Tang, W. Y. Lau, Jia Fan, Jiping Wang, Jian Zhou	204
15	Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma 2017 ·Clinical Cancer Research ·Yun‐Fan Sun, Wei Guo, Yang Xu, (unknown), Zijun Gong, Yuan Ji, Min Du, Xin Zhang, Bo Hu, Ao Huang, George G. Chen, Paul B.S. Lai, Ya Cao, Shuang–Jian Qiu, Jian Zhou, Xin‐Rong Yang, Jia Fan	123
16	Clinical Significance of EpCAM mRNA-Positive Circulating Tumor Cells in Hepatocellular Carcinoma by an Optimized Negative Enrichment and qRT-PCR–Based Platform 2014 ·Clinical Cancer Research ·Wei Guo, Xin‐Rong Yang, Yun‐Fan Sun, Minna Shen, Xiaolu Ma, Jiong Wu, (unknown), Yan Zhou, Yang Xu, Bo Hu, Xin Zhang, Jian Zhou, Jia Fan	98
17	Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma breakdown → 2014 ·Clinical Cancer Research ·Bo Hu, Xin‐Rong Yang, Yang Xu, Yun‐Fan Sun, Chao Sun, Wei Guo, Xin Zhang, Weimin Wang, Shuang–Jian Qiu, Jian Zhou, Jia Fan	1558
18	Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition 2011 ·Clinical Cancer Research ·Kai Zhu, Zhi Dai, Qi Pan, Zheng Wang, Guo‐Huan Yang, Lei Yu, Zhen‐Bin Ding, Guo‐Ming Shi, Ai‐Wu Ke, Xin‐Rong Yang, Zhonghua Tao, Yiming Zhao, Yi Qin, Haiying Zeng, Zhao–You Tang, Jia Fan, Jian Zhou	122
19	Polymeric Nanoparticle-Encapsulated Hedgehog Pathway Inhibitor HPI-1 (NanoHHI) Inhibits Systemic Metastases in an Orthotopic Model of Human Hepatocellular Carcinoma 2011 ·Clinical Cancer Research ·Yang Xu, Venugopal Chenna, Chaoxin Hu, (unknown), Mehtab Khan, Haibo Bai, Xin‐Rong Yang, Qingfeng Zhu, Yun‐Fan Sun, Anirban Maitra, Jia Fan, Robert A. Anders	60
20	CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery 2009 ·Clinical Cancer Research ·Xin‐Rong Yang, Yang Xu, Bin Yu, Jian Zhou, (unknown), Shuang–Jian Qiu, Ying‐Hong Shi, Xiaoying Wang, Zhi Dai, Guo‐Ming Shi, Bin Wu, Liming Wu, Guo‐Huan Yang, Boheng Zhang, Wenxin Qin, Jia Fan	129

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact